Editorial: Innovative approaches to immune tolerance and regulation with gene, cellular, protein, and microbiome based therapeutics

• Amy Rosenberg,
• Dawn Elaine Smilek,
• Dawn Elaine Smilek

Affiliations

Amy Rosenberg

EpiVax, Inc, Providence, RI, United States

Dawn Elaine Smilek

Immune Tolerance Network, San Francisco, CA, United States

Dawn Elaine Smilek

University of California San Francisco, Division of Rheumatology, San Francisco, CA, United States